Nasdaq · CIK 0001822791
CLNN Clene Inc.
Insider trading from SEC Form 4. Last filing 24 d ago. Close $3.86 on Oct 9, 2026, +18% from the 52-week low and -69% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
CLNNOct 9, 2026 · close 3.86
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Clene Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Chidozie Ugwumba owner sell | $73k 12,234 shares | -2% | +149% from low-53% from high | |
| 20Weak | Chidozie Ugwumba owner sell | $73k 11,671 shares | -1% | +164% from low-50% from high | |
| 20Weak | Chidozie Ugwumba owner sell | $65k 9,949 shares | -3% | +182% from low-47% from high | |
| 47Moderate | Chidozie Ugwumba owner sell | $1.7M 257,795 shares | -40% | +205% from low-42% from high | |
| 12Weak | General Resonance LLC owner sell | $18k 3,401 shares | -0% | +125% from low-21% from high | |
| 12Weak | General Resonance LLC owner sell | $2,424 600 shares | -0% | +70% from low-40% from high | |
| 12Weak | General Resonance LLC owner sell | $2,473 600 shares | -0% | +107% from low-27% from high | |
| 12Weak | General Resonance LLC owner sell | $1,148 410 shares | -0% | +35% from low-53% from high | |
| 12Weak | General Resonance LLC owner sell | $1,119 410 shares | -0% | +16% from low-59% from high | |
| 12Weak | General Resonance LLC owner sell | $1,090 420 shares | -0% | +11% from low-61% from high | |
| 12Weak | General Resonance LLC owner sell | $1,029 420 shares | -0% | +11% from low-61% from high | |
| 12Weak | General Resonance LLC owner sell | $12k 2,733 shares | -0% | - |
Transactions
The last 92 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Robert Dee Etherington President & CEO | AGrant or award common stock | +15,244 | $3.28 | $50k | 55,393 | 24 d ago |
| Sep 16, 2026 | David J Matlin director | AGrant or award common stock | +434,451 | $3.28 | $1.4M | 912,275 | 24 d ago |
| Sep 16, 2026 | Alison Mosca director, owner | AGrant or award common stockindirect: By LLC | +198,171 | $3.28 | $650k | 478,671 | 24 d ago |
| Dec 29, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -8,096 | $5.95 | $48k | 787,728 | Dec 31, 2025 |
| Dec 30, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -4,138 | $6.03 | $25k | 783,590 | Dec 31, 2025 |
| Dec 23, 2025 | Chidozie Ugwumba owner | EExpiration of short derivative Common Stockindirect: By Symbiosis II, LLC | +424,358 | $0.00 | $424 | 807,495 | Dec 30, 2025 |
| Dec 23, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -6,831 | $6.27 | $43k | 800,664 | Dec 30, 2025 |
| Dec 24, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -1,490 | $6.27 | $9,342 | 799,174 | Dec 30, 2025 |
| Dec 26, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -3,350 | $6.32 | $21k | 795,824 | Dec 30, 2025 |
| Dec 23, 2025 | Chidozie Ugwumba owner | EExpiration of short derivative Pre-Funded Warrant to Purchase Common Stockderivativeindirect: By Symbiosis II, LLC | -424,358 | $4.59 | $1.9M | 0 | Dec 30, 2025 |
| Dec 19, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,582 | $6.45 | $36k | 387,568 | Dec 23, 2025 |
| Dec 22, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -4,367 | $6.54 | $29k | 383,201 | Dec 23, 2025 |
| Dec 3, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -56,577 | $7.86 | $445k | 594,368 | Dec 18, 2025 |
| Dec 4, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -72,748 | $6.73 | $490k | 521,620 | Dec 18, 2025 |
| Dec 5, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -37,235 | $5.94 | $221k | 484,385 | Dec 18, 2025 |
| Dec 8, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -21,463 | $5.70 | $122k | 462,922 | Dec 18, 2025 |
| Dec 9, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -15,031 | $5.95 | $89k | 447,891 | Dec 18, 2025 |
| Dec 10, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -9,921 | $6.42 | $64k | 437,970 | Dec 18, 2025 |
| Dec 11, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -10,907 | $6.81 | $74k | 427,063 | Dec 18, 2025 |
| Dec 12, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -7,603 | $6.79 | $52k | 419,460 | Dec 18, 2025 |
| Dec 15, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -10,580 | $6.49 | $69k | 408,880 | Dec 18, 2025 |
| Dec 16, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -7,030 | $6.31 | $44k | 401,850 | Dec 18, 2025 |
| Dec 17, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -2,884 | $6.61 | $19k | 398,966 | Dec 18, 2025 |
| Dec 18, 2025 | Chidozie Ugwumba owner | SOpen-market sale Common Stockindirect: By Symbiosis II, LLC | -5,816 | $6.33 | $37k | 393,150 | Dec 18, 2025 |
| Nov 13, 2025 | Alison Mosca director | AGrant or award stock optionderivative | +2,887 | $0.00 | $0 | 2,887 | Nov 14, 2025 |
| Nov 13, 2025 | Matthew Kiernan director | AGrant or award stock optionderivative | +1,893 | $0.00 | $0 | 1,893 | Nov 14, 2025 |
| Nov 13, 2025 | Jonathon Gay director | AGrant or award stock optionderivative | +2,438 | $0.00 | $0 | 2,438 | Nov 14, 2025 |
| Nov 13, 2025 | Shalom Jacobovitz director | AGrant or award stock optionderivative | +2,816 | $0.00 | $0 | 2,816 | Nov 14, 2025 |
| Nov 13, 2025 | Arjun JJ Desai director | AGrant or award stock optionderivative | +2,177 | $0.00 | $0 | 2,177 | Nov 14, 2025 |
| Nov 13, 2025 | Vallerie McLaughlin director | AGrant or award stock optionderivative | +2,083 | $0.00 | $0 | 2,083 | Nov 14, 2025 |
| Nov 13, 2025 | Reed N Wilcox director | AGrant or award stock optionderivative | +1,893 | $0.00 | $0 | 1,893 | Nov 14, 2025 |
| Nov 13, 2025 | David J Matlin director | AGrant or award stock optionderivative | +3,692 | $0.00 | $0 | 3,692 | Nov 14, 2025 |
| Sep 25, 2025 | Mark Mortenson Chief Science Officer | AGrant or award stock optionderivative | +40,000 | $0.00 | $0 | 40,000 | Sep 30, 2025 |
| Sep 25, 2025 | Robert Dee Etherington President & CEO | AGrant or award stock optionderivative | +40,000 | $0.00 | $0 | 40,000 | Sep 30, 2025 |
| Sep 25, 2025 | Mark Mortenson Chief Science Officer | AGrant or award stock optionderivative | +40,000 | $0.00 | $0 | 40,000 | Sep 29, 2025 |
| Sep 25, 2025 | Robert Dee Etherington President & CEO | AGrant or award stock optionderivative | +40,000 | $0.00 | $0 | 40,000 | Sep 29, 2025 |
| Sep 25, 2025 | Morgan R Brown Chief Financial Officer | AGrant or award stock optionderivative | +10,000 | $0.00 | $0 | 10,000 | Sep 29, 2025 |
| Sep 18, 2025 | Morgan R Brown Chief Financial Officer | AGrant or award stock optionderivative | +10,000 | $0.00 | $0 | 10,000 | Sep 19, 2025 |
| Sep 18, 2025 | Mark Mortenson Chief Science Officer | AGrant or award stock optionderivative | +10,000 | $0.00 | $0 | 10,000 | Sep 19, 2025 |
| Sep 18, 2025 | Robert Dee Etherington President & CEO | AGrant or award stock optionderivative | +10,000 | $0.00 | $0 | 10,000 | Sep 19, 2025 |
| Aug 21, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -3,401 | $5.34 | $18k | 704,591 | Aug 21, 2025 |
| Aug 14, 2025 | Vallerie McLaughlin director | AGrant or award stock optionderivative | +4,092 | $0.00 | $0 | 4,092 | Aug 15, 2025 |
| Aug 14, 2025 | David J Matlin director | AGrant or award stock optionderivative | +7,255 | $0.00 | $0 | 7,255 | Aug 15, 2025 |
| Aug 14, 2025 | Matthew Kiernan director | AGrant or award stock optionderivative | +3,720 | $0.00 | $0 | 3,720 | Aug 15, 2025 |
| Aug 14, 2025 | Alison Mosca director | AGrant or award stock optionderivative | +5,674 | $0.00 | $0 | 5,674 | Aug 15, 2025 |
| Aug 14, 2025 | Jonathon Gay director | AGrant or award stock optionderivative | +4,790 | $0.00 | $0 | 4,790 | Aug 15, 2025 |
| Aug 14, 2025 | Arjun JJ Desai director | AGrant or award stock optionderivative | +4,278 | $0.00 | $0 | 4,278 | Aug 15, 2025 |
| Aug 14, 2025 | Reed N Wilcox director | AGrant or award stock optionderivative | +3,720 | $0.00 | $0 | 3,720 | Aug 15, 2025 |
| Aug 14, 2025 | Shalom Jacobovitz director | AGrant or award stock optionderivative | +5,534 | $0.00 | $0 | 5,534 | Aug 15, 2025 |
| Jun 4, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -600 | $4.04 | $2,424 | 707,992 | Jun 4, 2025 |
| Jun 2, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -600 | $4.12 | $2,473 | 708,592 | Jun 2, 2025 |
| May 30, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -410 | $2.80 | $1,148 | 709,192 | May 30, 2025 |
| May 29, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -410 | $2.73 | $1,119 | 709,602 | May 29, 2025 |
| May 28, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -420 | $2.60 | $1,090 | 710,012 | May 28, 2025 |
| May 27, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -420 | $2.45 | $1,029 | 710,432 | May 27, 2025 |
| May 22, 2025 | David J Matlin director | AGrant or award Stock Options (Right to buy)derivative | +10,209 | $0.00 | $0 | 10,209 | May 23, 2025 |
| May 22, 2025 | Jonathon Gay director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Arjun JJ Desai director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Shalom Jacobovitz director | AGrant or award Stock Options (Right to buy)derivative | +7,788 | $0.00 | $0 | 7,788 | May 23, 2025 |
| May 22, 2025 | Alison Mosca director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Matthew Kiernan director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Vallerie McLaughlin director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Reed N Wilcox director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Matthew Kiernan director | AGrant or award Stock Options (Right to buy)derivative | +5,236 | $0.00 | $0 | 5,236 | May 23, 2025 |
| May 22, 2025 | David J Matlin director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Arjun JJ Desai director | AGrant or award Stock Options (Right to buy)derivative | +6,021 | $0.00 | $0 | 6,021 | May 23, 2025 |
| May 22, 2025 | Shalom Jacobovitz director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | Alison Mosca director | AGrant or award Stock Options (Right to buy)derivative | +7,984 | $0.00 | $0 | 7,984 | May 23, 2025 |
| May 22, 2025 | Vallerie McLaughlin director | AGrant or award Stock Options (Right to buy)derivative | +5,759 | $0.00 | $0 | 5,759 | May 23, 2025 |
| May 22, 2025 | Reed N Wilcox director | AGrant or award Stock Options (Right to buy)derivative | +5,236 | $0.00 | $0 | 5,236 | May 23, 2025 |
| May 22, 2025 | Jonathon Gay director | AGrant or award Stock Options (Right to buy)derivative | +6,741 | $0.00 | $0 | 6,741 | May 23, 2025 |
| Mar 18, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -1,333 | $4.45 | $5,932 | 712,252 | Mar 19, 2025 |
| Mar 19, 2025 | General Resonance LLC owner | SOpen-market sale Common Stock | -1,400 | $4.40 | $6,160 | 710,852 | Mar 19, 2025 |
| Feb 27, 2025 | Alison Mosca director | AGrant or award Stock Options (Right to buy)derivative | +4,402 | $0.00 | $0 | 4,402 | Feb 28, 2025 |
| Feb 27, 2025 | Reed N Wilcox director | AGrant or award Stock Options (Right to buy)derivative | +2,886 | $0.00 | $0 | 2,886 | Feb 28, 2025 |
| Feb 27, 2025 | Matthew Kiernan director | AGrant or award Stock Options (Right to buy)derivative | +2,886 | $0.00 | $0 | 2,886 | Feb 28, 2025 |
| Feb 27, 2025 | Vallerie McLaughlin director | AGrant or award Stock Options (Right to buy)derivative | +3,175 | $0.00 | $0 | 3,175 | Feb 28, 2025 |
| Feb 27, 2025 | David J Matlin director | AGrant or award Stock Options (Right to buy)derivative | +5,628 | $0.00 | $0 | 5,628 | Feb 28, 2025 |
| Feb 27, 2025 | Shalom Jacobovitz director | AGrant or award Stock Options (Right to buy)derivative | +4,293 | $0.00 | $0 | 4,293 | Feb 28, 2025 |
| Feb 27, 2025 | Jonathon Gay director | AGrant or award Stock Options (Right to buy)derivative | +3,716 | $0.00 | $0 | 3,716 | Feb 28, 2025 |
| Feb 27, 2025 | Arjun JJ Desai director | AGrant or award Stock Options (Right to buy)derivative | +3,319 | $0.00 | $0 | 3,319 | Feb 28, 2025 |
| Feb 24, 2025 | Morgan R Brown Chief Financial Officer | AGrant or award Stock Options (Right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Feb 25, 2025 |
| Feb 24, 2025 | Mark Mortenson Chief Science Officer | AGrant or award Stock Options (Right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 25, 2025 |
| Feb 24, 2025 | Robert Dee Etherington Chief Executive Officer | AGrant or award Stock Options (Right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Feb 25, 2025 |
| Dec 6, 2024 | Matthew Kiernan director | AGrant or award Stock Options (Right to buy)derivative | +2,853 | $0.00 | $0 | 2,853 | Dec 9, 2024 |
| Dec 6, 2024 | Reed N Wilcox director | AGrant or award Stock Options (Right to buy)derivative | +2,853 | $0.00 | $0 | 2,853 | Dec 9, 2024 |
| Dec 6, 2024 | Alison Mosca director | AGrant or award Stock Options (Right to buy)derivative | +4,350 | $0.00 | $0 | 4,350 | Dec 9, 2024 |
| Dec 6, 2024 | David J Matlin director | AGrant or award Stock Options (Right to buy)derivative | +5,563 | $0.00 | $0 | 5,563 | Dec 9, 2024 |
| Dec 6, 2024 | Jonathon Gay director | AGrant or award Stock Options (Right to buy)derivative | +3,673 | $0.00 | $0 | 3,673 | Dec 9, 2024 |
| Dec 6, 2024 | Shalom Jacobovitz director | AGrant or award Stock Options (Right to buy)derivative | +4,243 | $0.00 | $0 | 4,243 | Dec 9, 2024 |
| Dec 6, 2024 | Arjun JJ Desai director | AGrant or award Stock Options (Right to buy)derivative | +3,280 | $0.00 | $0 | 3,280 | Dec 9, 2024 |
| Dec 6, 2024 | Vallerie McLaughlin director | AGrant or award Stock Options (Right to buy)derivative | +3,138 | $0.00 | $0 | 3,138 | Dec 9, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Morgan R BrownChief Financial Officer
- Arjun JJ Desaidirector
- Robert Dee EtheringtonPresident & CEO
- Jonathon Gaydirector
- General Resonance LLCowner
- Shalom Jacobovitzdirector
- Matthew Kiernandirector
- David J Matlindirector
- Vallerie McLaughlindirector
- Mark MortensonChief Science Officer
- Alison Moscadirector, owner
- Chidozie Ugwumbaowner
- Reed N Wilcoxdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.